Prevalence of Drug-Resistant Tuberculosis in Sudan: A Systematic Review and Meta-Analysis
Open Access
- 31 July 2021
- journal article
- review article
- Published by MDPI AG in Antibiotics
- Vol. 10 (8) , 932
Abstract
Drug-resistant tuberculosis (DR-TB) is still one of the most critical issues impeding worldwide TB control efforts. The aim of this systematic review and meta-analysis was to give an updated picture of the prevalence of DR-TB in Sudan. A comprehensive systematic search was performed on four electronic databases (PubMed, Scopus, Web of Science and Google Scholar) to identify all published studies reporting prevalence data of DR-TB in Sudan. Sixteen eligible studies published during 2002–2020 were included. Using meta-analysis of proportions, the pooled prevalence of TB cases with resistance to any anti-TB drugs was 47.0% (95% CI: 35.5–58.6%). The overall prevalence of mono, multi, poly and extensive drug resistance were estimated to be 16.2% (95% CI: 9.0–23.4%), 22.8% (95% CI: 16.0–29.7%), 6.8% (95% CI: 0.5–13.0%) and 0.7% (95% CI: 0–2.1%), respectively. Considering any first-line anti-TB drugs, the resistance prevalence was highest for isoniazid (32.3%) and streptomycin (31.7%), followed by rifampicin (29.2%). In contrast, resistance against second-line drugs was reported for only two antibiotics, namely, ofloxacin (2.1%) and kanamycin (0.7%). Of note, the resistance profile of the previously treated patients was found to be remarkably high compared with the newly diagnosed TB patients. The relatively high prevalence estimation of anti-TB drug resistance warrants strengthening TB control and treatment strategies in Sudan.Keywords
This publication has 57 references indexed in Scilit:
- Multi-drug resistance tuberculosis (MDR-TB) in Kassala State, Eastern SudanTropical Doctor, 2013
- Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from ChinaThorax, 2012
- A study on Prevalence of Drug Resistance in Drug Default Pulmonary TuberculosisSudan Journal of Medical Sciences, 2011
- Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosisBMC Infectious Diseases, 2011
- Risk Factors for MDR and XDR-TB in a Tertiary Referral Hospital in IndiaPLOS ONE, 2010
- Drivers of tuberculosis epidemics: The role of risk factors and social determinantsSocial Science & Medicine, 2009
- High prevalence of multidrug-resistant tuberculosis in GeorgiaInternational Journal of Infectious Diseases, 2008
- Risk factors for multidrug resistant tuberculosis in Europe: a systematic reviewThorax, 2006
- Strategies against multidrug-resistant tuberculosisEuropean Respiratory Journal, 2002
- Molecular Analysis of Clinical Isolates of Mycobacterium tuberculosis Collected from Patients with Persistent Disease in the Khartoum Region of SudanJournal of Infection, 2002